Current and historical daily PE Ratio for HQL (
abrdn Life Sciences Investors
) from 1990 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. abrdn Life Sciences Investors stock (HQL) PE ratio as of May 12 2024 is 17.53.
More Details
abrdn Life Sciences Investors (HQL) PE Ratio (TTM) Chart
abrdn Life Sciences Investors (HQL) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1163
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| abrdn Life Sciences Investors PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-12 | 17.5 | 2024-03-08 | 17.4 |
| 2024-05-10 | 17.5 | 2024-03-07 | 17.4 |
| 2024-05-09 | 17.5 | 2024-03-06 | 17.5 |
| 2024-05-08 | 17.3 | 2024-03-05 | 17.4 |
| 2024-05-07 | 17.4 | 2024-03-04 | 17.6 |
| 2024-05-06 | 17.3 | 2024-03-01 | 17.6 |
| 2024-05-03 | 17.2 | 2024-02-29 | 17.3 |
| 2024-05-02 | 17.1 | 2024-02-28 | 17.6 |
| 2024-05-01 | 16.8 | 2024-02-27 | 17.7 |
| 2024-04-30 | 16.6 | 2024-02-26 | 17.5 |
| 2024-04-29 | 16.6 | 2024-02-23 | 17.5 |
| 2024-04-26 | 16.4 | 2024-02-22 | 17.5 |
| 2024-04-25 | 16.4 | 2024-02-21 | 17.3 |
| 2024-04-24 | 16.6 | 2024-02-20 | 17.9 |
| 2024-04-23 | 16.6 | 2024-02-16 | 17.9 |
| 2024-04-22 | 16.4 | 2024-02-15 | 17.8 |
| 2024-04-19 | 16.2 | 2024-02-14 | 17.7 |
| 2024-04-18 | 16.2 | 2024-02-13 | 17.8 |
| 2024-04-17 | 16.2 | 2024-02-12 | 17.9 |
| 2024-04-16 | 16.2 | 2024-02-09 | 17.5 |
| 2024-04-15 | 16.4 | 2024-02-08 | 17.5 |
| 2024-04-12 | 16.5 | 2024-02-07 | 17.6 |
| 2024-04-11 | 16.7 | 2024-02-06 | 17.6 |
| 2024-04-10 | 16.7 | 2024-02-05 | 17.6 |
| 2024-04-09 | 16.9 | 2024-02-02 | 17.5 |
| 2024-04-08 | 16.8 | 2024-02-01 | 17.6 |
| 2024-04-05 | 16.8 | 2024-01-31 | 17.4 |
| 2024-04-04 | 16.6 | 2024-01-30 | 17.4 |
| 2024-04-03 | 16.8 | 2024-01-29 | 17.5 |
| 2024-04-02 | 16.7 | 2024-01-26 | 17.3 |
| 2024-04-01 | 17.1 | 2024-01-25 | 17.5 |
| 2024-03-28 | 17.3 | 2024-01-24 | 17.5 |
| 2024-03-27 | 17.3 | 2024-01-23 | 17.7 |
| 2024-03-26 | 17.1 | 2024-01-22 | 17.6 |
| 2024-03-25 | 17.1 | 2024-01-19 | 17.7 |
| 2024-03-22 | 17.1 | 2024-01-18 | 17.6 |
| 2024-03-21 | 17.2 | 2024-01-17 | 17.6 |
| 2024-03-20 | 17.0 | 2024-01-16 | 17.8 |
| 2024-03-19 | 17.0 | 2024-01-12 | 17.9 |
| 2024-03-18 | 16.9 | 2024-01-11 | 17.9 |
| 2024-03-15 | 17.1 | 2024-01-10 | 18.1 |
| 2024-03-14 | 17.2 | 2024-01-09 | 18.0 |
| 2024-03-13 | 17.5 | 2024-01-08 | 18.0 |
| 2024-03-12 | 17.5 | 2024-01-05 | 17.6 |
| 2024-03-11 | 17.4 | 2024-01-04 | 17.6 |
abrdn Life Sciences Investors (HQL) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
abrdn Life Sciences Investors
NAICS : 523930
SIC : 6282
ISIN : US87911K1007
Share Class Description:
HQL: CE with IsEquityFundamentalDataAvailable = 1 in GidDescription
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers